Analyst Price Targets — DHR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 6, 2026 12:41 pm | Vijay Kumar | Evercore ISI | $230.00 | $190.60 | TheFly | Danaher price target lowered to $230 from $232 at Evercore ISI |
| June 11, 2026 9:51 am | — | Piper Sandler | $200.00 | $183.63 | TheFly | Danaher initiated with a Neutral at Piper Sandler |
| June 3, 2026 9:25 am | — | HSBC | $230.00 | $176.11 | TheFly | Danaher price target lowered to $230 from $270 at HSBC |
| May 14, 2026 8:22 pm | — | RBC Capital | $200.00 | $164.54 | TheFly | Danaher resumed with an Outperform at RBC Capital |
| April 21, 2026 6:05 pm | Tycho Peterson | Jefferies | $245.00 | $194.45 | TheFly | Danaher price target raised to $245 from $240 at Jefferies |
| April 17, 2026 10:42 am | Catherine Ramsey Schulte | Robert W. Baird | $249.00 | $193.78 | TheFly | Danaher price target lowered to $249 from $251 at Baird |
| April 17, 2026 8:49 am | — | Redburn Partners | $205.00 | $193.78 | TheFly | Danaher price target lowered to $205 from $220 at Rothschild & Co Redburn |
| April 14, 2026 10:42 am | — | Barclays | $230.00 | $195.87 | TheFly | Danaher price target lowered to $230 from $250 at Barclays |
| January 29, 2026 12:43 pm | — | Robert W. Baird | $251.00 | $224.54 | TheFly | Danaher price target raised to $251 from $247 at Baird |
| January 28, 2026 7:59 pm | — | Jefferies | $265.00 | $224.54 | TheFly | Danaher price target raised to $265 from $255 at Jefferies |
Latest News for DHR
Allspring Global Investments Holdings LLC lessened its position in shares of Danaher Corporation (NYSE: DHR) by 2.5% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 473,207 shares of the conglomerate's stock after selling 12,254 shares during the period. Allspring Global Investments
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
DHR heads into Q2 earnings with bioprocessing and diagnostics strength, but rising costs and debt could pressure profitability.
Besides Wall Street's top-and-bottom-line estimates for Danaher (DHR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.
Investors need to pay close attention to DHR stock based on the movements in the options market lately.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.